Impurity Profiling of a New Drug Entity - Couverture souple

Mishra Neeraj; Baldi Ashish; Rawal Ravindra K

9783846580127: Impurity Profiling of a New Drug Entity

Couverture souple

ISBN 10 : 3846580120 ISBN 13 : 9783846580127

Editeur : LAP Lambert Academic Publishing, 2014

Afficher les exemplaires de cette �dition comportant l?ISBN

0 D'occasion

7 Neuf

De EUR 34,25

Le profilage des impuret�s et les voies de d�gradation des m�dicaments sont des caract�ristiques essentielles pour l'acceptation r�glementaire de toute nouvelle entit� m�dicamenteuse. Malgr� les progr�s technologiques dans l'analyse pharmaceutique, l'�lucidation structurelle des mol�cules de m�dicaments, les impuret�s produites lors de la formulation restent des t�ches difficiles pour les chercheurs. Le comportement chimique unique, les propri�t�s complexes et les interactions de diff�rents groupes fonctionnels impliqu�s dans les ingr�dients pharmaceutiques actifs ainsi que diff�rents environnements chimiques avec des excipients et des conditions de stockage compliquent encore les probl�mes. En outre, l'isolement et la caract�risation des impuret�s avec des r�f�rences sp�ciales aux m�tabolites toxiques sont essentielles pour l'acceptation de nouvelles mol�cules de m�dicaments par les organismes de r�glementation. Des esters de nitrate de parac�tamol r�cemment d�couverts et brevet�s ayant des activit�s analg�siques et anti-inflammatoires am�lior�es, puis le m�dicament parent et moins d'h�patotoxicit� en cas de surdosage sont s�lectionn�s comme entit� m�dicamenteuse mod�le. Ce livre est une tentative de fournir des informations exp�rimentales sur la chimie, l'analyse et l'�tablissement de voies de d�gradation des m�dicaments dans des conditions forc�es de mani�re lucide pour une compr�hension facile pour r�pondre aux attentes futures des fraternit�s scientifiques.

Les informations fournies dans la section � Synopsis � peuvent faire r�f�rence � une autre �dition de ce titre.

�diteur: LAP Lambert Academic Publishing
Date d'�dition: 2014
Langue: anglais
ISBN 10: 3846580120
ISBN 13: 9783846580127
Reliure: Broch�
Nombre de pages: 80
Coordonn�es du fabricant: non disponible
Personne responsable: KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne

Acheter neuf

Afficher cet article

EUR 34,25

Autre devise

EUR 9,70 exp�dition depuis Allemagne vers France

Destinations, frais et d�lais

Ajouter au panier

R�sultats de recherche pour Impurity Profiling of a New Drug Entity

Image fournie par le vendeur

Impurity Profiling of a New Drug Entity

Neeraj Mishra|Ashish Baldi|Ravindra K. Rawal

Edit� par LAP LAMBERT Academic Publishing, 2014

ISBN 10 : 3846580120 ISBN 13 : 9783846580127

Neuf Couverture souple

impression � la demande

Vendeur : moluna, Greven, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Mishra NeerajDr. Neeraj Mishra is currently working as associate professor in ISF College of Pharmacy, Moga, Punjab, India. With 1 patent and over 40 publications of International and National repute, he is an active researcher in Ph. N� de r�f. du vendeur 5501019

Contacter le vendeur

Acheter neuf

EUR 34,25

Autre devise

Frais de port : EUR 9,70

De Allemagne vers France

Destinations, frais et d�lais

Quantit� disponible : Plus de 20 disponibles

Ajouter au panier

Image fournie par le vendeur

Impurity Profiling of a New Drug Entity

Neeraj Mishra

Edit� par LAP LAMBERT Academic Publishing Feb 2014, 2014

ISBN 10 : 3846580120 ISBN 13 : 9783846580127

Neuf Taschenbuch

impression � la demande

Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Impurity profiling and drug degradation pathways are essentials features for regulatory acceptance of any new drug entity. Despite of technological advancements in pharmaceutical analysis, structural elucidation of drug molecules, impurities produced during formulation remains challenging tasks for researchers. Unique chemical behavior, complex properties and interactions of different functional groups involved in active pharmaceutical ingredients along with different chemical environments with excipients and storage condition further complicate the issues. Furthermore isolation and characterization of impurities with special references to toxic metabolites is essential for acceptance of new drug molecules by regulatory agencies. Recently discovered and patented nitrate esters of paracetamol having improved analgesic and anti-inflammatory activities then parent drug and less hepatotoxicity in overdose is selected as model drug entity. This book is an attempt to provide experimental insights into the chemical, analytical and establishment of drug degradation pathways in forced conditions in lucid manner for easy understanding to meet future expectations of scientific fraternities. 80 pp. Englisch. N� de r�f. du vendeur 9783846580127

Contacter le vendeur

Acheter neuf

EUR 35,90

Autre devise

Frais de port : EUR 11

De Allemagne vers France

Destinations, frais et d�lais

Quantit� disponible : 2 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Impurity Profiling of a New Drug Entity : Experimental Insights

Neeraj Mishra

Edit� par LAP LAMBERT Academic Publishing, 2014

ISBN 10 : 3846580120 ISBN 13 : 9783846580127

Neuf Taschenbuch

impression � la demande

Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Impurity profiling and drug degradation pathways are essentials features for regulatory acceptance of any new drug entity. Despite of technological advancements in pharmaceutical analysis, structural elucidation of drug molecules, impurities produced during formulation remains challenging tasks for researchers. Unique chemical behavior, complex properties and interactions of different functional groups involved in active pharmaceutical ingredients along with different chemical environments with excipients and storage condition further complicate the issues. Furthermore isolation and characterization of impurities with special references to toxic metabolites is essential for acceptance of new drug molecules by regulatory agencies. Recently discovered and patented nitrate esters of paracetamol having improved analgesic and anti-inflammatory activities then parent drug and less hepatotoxicity in overdose is selected as model drug entity. This book is an attempt to provide experimental insights into the chemical, analytical and establishment of drug degradation pathways in forced conditions in lucid manner for easy understanding to meet future expectations of scientific fraternities. N� de r�f. du vendeur 9783846580127

Contacter le vendeur

Acheter neuf

EUR 39,90

Autre devise

Frais de port : EUR 10,99

De Allemagne vers France

Destinations, frais et d�lais

Quantit� disponible : 1 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Impurity Profiling of a New Drug Entity

Neeraj Mishra

Edit� par LAP LAMBERT Academic Publishing Feb 2014, 2014

ISBN 10 : 3846580120 ISBN 13 : 9783846580127

Neuf Taschenbuch

impression � la demande

Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Impurity profiling and drug degradation pathways are essentials features for regulatory acceptance of any new drug entity. Despite of technological advancements in pharmaceutical analysis, structural elucidation of drug molecules, impurities produced during formulation remains challenging tasks for researchers. Unique chemical behavior, complex properties and interactions of different functional groups involved in active pharmaceutical ingredients along with different chemical environments with excipients and storage condition further complicate the issues. Furthermore isolation and characterization of impurities with special references to toxic metabolites is essential for acceptance of new drug molecules by regulatory agencies. Recently discovered and patented nitrate esters of paracetamol having improved analgesic and anti-inflammatory activities then parent drug and less hepatotoxicity in overdose is selected as model drug entity. This book is an attempt to provide experimental insights into the chemical, analytical and establishment of drug degradation pathways in forced conditions in lucid manner for easy understanding to meet future expectations of scientific fraternities.Books on Demand GmbH, �berseering 33, 22297 Hamburg 80 pp. Englisch. N� de r�f. du vendeur 9783846580127

Contacter le vendeur